196 related articles for article (PubMed ID: 16925667)
1. Effect of tandem forms of DAF(CD55) on complement-mediated xenogeneic cell lysis.
Miyagawa S; Fukuta D; Kitano E; Kobayashi C; Fumimoto Y; Shirasu A; Hattori H; Shirakura R; Fukuzawa M
Xenotransplantation; 2006 Sep; 13(5):433-9. PubMed ID: 16925667
[TBL] [Abstract][Full Text] [Related]
2. Expression of complement regulatory protein on porcine endogenous retrovirus (PERV) depends on molecular size.
Yamamoto A; Kobayashi C; Yamashita S; Miyazawa T; Okabe M; Fukuzawa M; Miyagawa S
Transpl Immunol; 2010 May; 23(1-2):71-6. PubMed ID: 20226243
[TBL] [Abstract][Full Text] [Related]
3. Differential human serum-mediated neutralization of PERV released from pig cells transfected with variants of hDAF.
Okura E; Ishimaru A; Yamamoto A; Nakatsu S; Shirakura R; Okabe M; Sawa Y; Fukuzawa M; Okumura M; Miyagawa S
Xenotransplantation; 2008; 15(6):365-73. PubMed ID: 19152664
[TBL] [Abstract][Full Text] [Related]
4. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor.
Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I
Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603
[TBL] [Abstract][Full Text] [Related]
5. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression.
Omori T; Nishida T; Komoda H; Fumimoto Y; Ito T; Sawa Y; Gao C; Nakatsu S; Shirakura R; Miyagawa S
Xenotransplantation; 2006 Sep; 13(5):455-64. PubMed ID: 16925670
[TBL] [Abstract][Full Text] [Related]
6. Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis.
Fukuta D; Miyagawa S; Yamada M; Matsunami K; Kurihara T; Shirasu A; Hattori H; Shirakura R
Xenotransplantation; 2003 Mar; 10(2):132-41. PubMed ID: 12588646
[TBL] [Abstract][Full Text] [Related]
7. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
Iwata K; Seya T; Ariga H; Nagasawa S
J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
[TBL] [Abstract][Full Text] [Related]
8. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis.
Kuraya M; Yefenof E; Klein G; Klein E
Eur J Immunol; 1992 Jul; 22(7):1871-6. PubMed ID: 1378022
[TBL] [Abstract][Full Text] [Related]
9. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis.
Miyagawa S; Shirakura R; Iwata K; Nakata S; Matsumiya G; Izutani H; Matsuda H; Terado A; Matsumoto M; Nagasawa S
Transplantation; 1994 Oct; 58(7):834-40. PubMed ID: 7524206
[TBL] [Abstract][Full Text] [Related]
10. Human DAF on pig cells protects against human and non-human primate sera cytotoxicity mediated by exogenous or endogenous complement, as determined by flow cytometry.
Díaz-Román TM; Mañez R; López-Pelaez E; Centeno A; Moscoso I; Pértegaz S; Doménech N
Transpl Immunol; 2006 Aug; 16(2):125-30. PubMed ID: 16860716
[TBL] [Abstract][Full Text] [Related]
11. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor.
Coyne KE; Hall SE; Thompson S; Arce MA; Kinoshita T; Fujita T; Anstee DJ; Rosse W; Lublin DM
J Immunol; 1992 Nov; 149(9):2906-13. PubMed ID: 1383332
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum.
Schmidt P; Goto M; Le Mauff B; Anegon I; Korsgren O
Transplantation; 2003 Mar; 75(5):697-702. PubMed ID: 12640312
[TBL] [Abstract][Full Text] [Related]
13. Delta-short consensus repeat 4-decay accelerating factor (DAF: CD55) inhibits complement-mediated cytolysis but not NK cell-mediated cytolysis.
Miyagawa S; Kubo T; Matsunami K; Kusama T; Beppu K; Nozaki H; Moritan T; Ahn C; Kim JY; Fukuta D; Shirakura R
J Immunol; 2004 Sep; 173(6):3945-52. PubMed ID: 15356143
[TBL] [Abstract][Full Text] [Related]
14. Mapping of binding epitopes of a human decay-accelerating factor monoclonal antibody capable of enhancing rituximab-mediated complement-dependent cytotoxicity.
Guo B; Ma ZW; Li H; Xu GL; Zheng P; Zhu B; Wu YZ; Zou Q
Clin Immunol; 2008 Aug; 128(2):155-63. PubMed ID: 18502181
[TBL] [Abstract][Full Text] [Related]
15. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of novel splicing variants of human decay-accelerating factor.
Osuka F; Endo Y; Higuchi M; Suzuki H; Shio Y; Fujiu K; Kanno R; Oishi A; Terashima M; Fujita T; Gotoh M
Genomics; 2006 Sep; 88(3):316-22. PubMed ID: 16503113
[TBL] [Abstract][Full Text] [Related]
17. Only the light chain is sufficient for the serine protease function of the membrane bound form of factor I on a xeno-surface.
Fukuta D; Miyagawa S; Kubo T; Kusama T; Shirasu A; Hattori H; Shirakura R
Transpl Immunol; 2004 Jan; 12(2):109-14. PubMed ID: 14967308
[TBL] [Abstract][Full Text] [Related]
18. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium.
Miyagawa S; Shirakura R; Izutani H; Matsumiya G; Nakata S; Matsuda H; Iwata K; Nagasawa S; Terado A; Matsumoto M
Transplant Proc; 1994 Jun; 26(3):1253-4. PubMed ID: 7518122
[No Abstract] [Full Text] [Related]
19. Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity.
Shafren DR; Dorahy DJ; Thorne RF; Kinoshita T; Barry RD; Burns GF
J Immunol; 1998 Mar; 160(5):2318-23. PubMed ID: 9498772
[TBL] [Abstract][Full Text] [Related]
20. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
Harrower TP; Richards A; Cruz G; Copeman L; Dunnett SB; Barker RA
Xenotransplantation; 2004 Jan; 11(1):60-71. PubMed ID: 14962294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
